Cancer therapy with antibodies - Nature Reviews Cancer
May 13, 2024 · The Antibody Society is an association that supports research and development of antibody-based drugs and maintains an updated list of antibodies approved by the FDA and EMA.
The application of antibody-based agents in cancer therapy based on ...
Sep 1, 2025 · Monoclonal antibodies and antibody-based agents are undergoing remarkable development in cancer immunotherapy. Based on their structural components, these antibodies …
Monoclonal antibody drugs for cancer: How they work
Monoclonal antibody drugs are treatments that enlist your body's germ-fighting immune system against diseases, including cancer. If your health care provider recommends a monoclonal antibody drug as …
A comprehensive overview on antibody-drug conjugates: from the ...
Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer compounds that are widely used in the treatment of hematologic malignancies and solid tumors. Unlike conventional …
Targeted Antibodies - Cancer Research Institute
More recently, advances in technology have enabled the development of new antibody-based immunotherapies. One such approach is antibody-drug conjugates (ADCs), in which a targeted …
Monoclonal Antibodies and Their Side Effects - American Cancer Society
Cetuximab (Erbitux) is an antibody that targets a cell protein called EGFR, which is found on normal skin cells (as well as some types of cancer cells). This drug can cause serious rashes in some people. …
Advancements in antibody-drug conjugates as cancer therapeutics
Aug 1, 2025 · Antibody-drug conjugates (ADCs) represent a promising approach in targeted cancer therapy, combining the targeted precision of antibodies with the potency of cytotoxic payloads to …
Targeted cancer drugs and immunotherapy | Cancer Research UK
Feb 26, 2025 · Monoclonal antibodies (mAbs) Monoclonal antibodies are a type of cancer treatment. They can also be used to treat other conditions such as rheumatoid arthritis. Monoclonal antibodies …
Emerging new therapeutic antibody derivatives for cancer treatment
Feb 7, 2022 · IgG is the predominant antibody used in current antibody drugs, but in certain cases, the application of full-length antibody is limited in cancer treatment because these large antibodies such …
Comprehensive List of FDA-Approved Antibody-Drug Conjugates …
Oct 3, 2024 · Comprehensive List of FDA-Approved Antibody-Drug Conjugates (ADCs) – Updated for 2024 Overview: Antibody-Drug Conjugates (ADCs) represent a cutting-edge approach to cancer …